Development of iPSC-based clinical trial selection platform for patients with ultrarare diseases.

Sci Adv · 2022 · PMC8993122 · PMID 35394834

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

After treatment with the abovementioned three drugs (Ubi, ALA, and Ribo), there was a decreasing trend in the levels of these metabolites (fig.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.